Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Assembly Biosciences Inc (NASDAQ: ASMB) closed at $37.19 down -0.61% from its previous closing price of $37.42. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 61184.0 shares were traded. ASMB stock price reached its highest trading level at $37.93 during the session, while it also had its lowest trading level at $36.755.
Ratios:
For a deeper understanding of Assembly Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.44 and its Current Ratio is at 4.44. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, Citizens JMP on September 24, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $38.
On March 25, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $31.Guggenheim initiated its Buy rating on March 25, 2025, with a $31 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 31 ’25 when McHutchison John G sold 757 shares for $9.85 per share. The transaction valued at 7,455 led to the insider holds 18,347 shares of the business.
Bjorkquist Jeanette M sold 180 shares of ASMB for $1,773 on Mar 31 ’25. The Principal Accounting Officer now owns 4,617 shares after completing the transaction at $9.85 per share. On Mar 31 ’25, another insider, Okazaki Jason A, who serves as the CEO and President of the company, sold 355 shares for $9.85 each. As a result, the insider received 3,496 and left with 14,757 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASMB now has a Market Capitalization of 588239424 and an Enterprise Value of 358437440. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.82 while its Price-to-Book (P/B) ratio in mrq is 3.22. Its current Enterprise Value per Revenue stands at 9.638 whereas that against EBITDA is -8.274.
Stock Price History:
The Beta on a monthly basis for ASMB is 1.12, which has changed by 1.1960094 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, ASMB has reached a high of $39.71, while it has fallen to a 52-week low of $7.75. The 50-Day Moving Average of the stock is 24.74%, while the 200-Day Moving Average is calculated to be 92.03%.
Shares Statistics:
For the past three months, ASMB has traded an average of 150.55K shares per day and 182680 over the past ten days. A total of 15.82M shares are outstanding, with a floating share count of 9.98M. Insiders hold about 36.93% of the company’s shares, while institutions hold 44.94% stake in the company. Shares short for ASMB as of 1763078400 were 1306741 with a Short Ratio of 8.68, compared to 1760486400 on 1534291. Therefore, it implies a Short% of Shares Outstanding of 1306741 and a Short% of Float of 9.68.
Earnings Estimates
A detailed examination of Assembly Biosciences Inc (ASMB) is currently in progress, with 4.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.65, with high estimates of -$0.5 and low estimates of -$0.8.
Analysts are recommending an EPS of between -$3.3 and -$4.31 for the fiscal current year, implying an average EPS of -$3.79. EPS for the following year is -$3.38, with 4.0 analysts recommending between -$2.31 and -$5.7.
Revenue Estimates
For the next quarter, 5 analysts are estimating revenue of $8.87M. There is a high estimate of $10.6M for the next quarter, whereas the lowest estimate is $8M.
A total of 5 analysts have provided revenue estimates for ASMB’s current fiscal year. The highest revenue estimate was $40.42M, while the lowest revenue estimate was $30M, resulting in an average revenue estimate of $36.83M. In the same quarter a year ago, actual revenue was $28.52M
